Impact of Islet Transplantation on Diabetes Complications and Mortality in Patients Living With Type 1 Diabetes
This study suggests long-term benefits of IT on diabetes-related outcomes. Furthermore, despite the use of immunosuppressive drugs following IT, we observed no significant increase in the risk of cancer. Altogether, these findings highlight a favorable risk-benefit ratio of IT in treating patients with unstable T1D.
Authors
- Emmanuel Morélon (ORCID: https://orcid.org/0000-0001-9928-1671)
- Sandrine Lablanche (ORCID: https://orcid.org/0000-0001-7044-8474)
- Camille Besch (ORCID: https://orcid.org/0000-0002-7992-1595)
- Orianne Villard (ORCID: https://orcid.org/0000-0002-7420-1425)
- Sophie Borot (ORCID: https://orcid.org/0000-0001-6240-8253)
- Thomas Jouvé (ORCID: https://orcid.org/0000-0001-9016-7506)
- V. Melki
- Matthieu Roustit (ORCID: https://orcid.org/0000-0003-4475-1626)
- M. Heim (ORCID: https://orcid.org/0000-0002-7858-4822)
- Clément Jambon-Barbara (ORCID: https://orcid.org/0000-0002-6619-4130)
- François Faitot (ORCID: https://orcid.org/0000-0001-6514-0774)
- Bénédicte Janbon
- Andrea Peloso (ORCID: https://orcid.org/0000-0002-3089-0230)
- Sabrina Granziera (ORCID: https://orcid.org/0009-0006-7653-8204)
- Géraldine Parnaud
- Fanny Buron (ORCID: https://orcid.org/0000-0003-0404-6746)
- M.N. Peraldi (ORCID: https://orcid.org/0000-0001-9956-3572)
- Antoine Dürrbach (ORCID: https://orcid.org/0000-0003-0385-8726)
- Fanny Lebreton (ORCID: https://orcid.org/0000-0002-3175-0205)
- Marie‐Christine Vantyghem (ORCID: https://orcid.org/0000-0002-9369-0463)
- Éric Renard (ORCID: https://orcid.org/0000-0002-3407-7263)
- Luc Rakotoarisoa (ORCID: https://orcid.org/0000-0001-9583-2130)
- Nadine Pernin
- Christophe Broca (ORCID: https://orcid.org/0000-0002-7715-8231)
- Charles G. Widmer
- Quentin Perrier (ORCID: https://orcid.org/0000-0002-7445-7922)
- Domenico Bosco (ORCID: https://orcid.org/0000-0003-3453-9613)
- Bruno Guerci (ORCID: https://orcid.org/0000-0002-6211-464X)
- Olivier Thaunat (ORCID: https://orcid.org/0000-0002-3648-8963)
- Paolo Malvezzi (ORCID: https://orcid.org/0000-0002-8549-5561)
- Pierre‐Yves Benhamou (ORCID: https://orcid.org/0000-0003-4378-0468)
- Mathieu Armanet (ORCID: https://orcid.org/0000-0001-6494-3380)
- Thierry Berney (ORCID: https://orcid.org/0000-0002-4230-9378)
- Johan Noble (ORCID: https://orcid.org/0000-0002-2329-0392)
- Laurence Kessler (ORCID: https://orcid.org/0000-0002-1769-5625)
- Charles‐Henri Wassmer (ORCID: https://orcid.org/0000-0002-9018-7088)
- Charles Thivolet (ORCID: https://orcid.org/0000-0002-0696-974X)
- Lionel Badet
- Igor Tauveron
- Laure Esposito
- Julia Sabatier
- Michel Greget
- Pierre Cattan
- Luc Frimat
- Ekaterine Berishvilli
- Ammanuel Morelon
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Université de Lille (FR)
- Regenerative NanoMedicine (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Lille’s Cardiology Hospital (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hospices Civils de Lyon (FR)
- University Hospital of Geneva (CH)
- Grenoble Institute of Neurosciences (FR)
- European Genomic Institute for Diabetes (FR)
- Geneva College (US)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-04-17
- DOI
- https://doi.org/10.2337/dc25-0059
- Citations
- 6
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 12.04
Funders
- Agence de la Biomédecine